United States Cannabis Market Report 2025 | Legalization Trends & Forecasts 2024-2033 Featuring Charlotte's Web, Canopy, NuLeaf, CV Sciences, Cronos, Organigram, Irwin Naturals, Tilray Brands, Aurora - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "United States Cannabis Market - Legalization Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Cannabis Market is expected to reach US$ 91.10 billion by 2033 from US$ 36.94 billion in 2024, with a CAGR of 10.55% from 2025 to 2033 Increased state-by-state legalization, an increase in medical applications, consumer acceptance, product innovation, growing retail infrastructure, investment inflows, favorable regu
Related Questions
How does the 10.55% CAGR from 2025‑2033 compare to growth expectations for other regulated sectors (e.g., alcohol, tobacco, or pharma) and what does that imply for sector rotation?
Are there any emerging competitive threats (e.g., new entrants, alternative cannabinoids) that could impact the market share of established players mentioned in the report?
How will the projected $91.10 billion market size by 2033 affect the valuation of major cannabis stocks like Cronos (CRON) and Tilray?
What short‑term catalysts could drive price movement in CRON following the release of this market forecast?
Which states’ upcoming legalization timelines are likely to create the biggest near‑term demand spikes for cannabis products?
What impact will increased medical applications and product innovation have on the revenue mix (recreational vs. medical) for companies such as Canopy, Aurora, and CV Sciences?
How might the expanding retail infrastructure and investment inflows affect supply‑chain dynamics and margins for growers versus downstream brands?
What are the potential regulatory risks (e.g., federal scheduling, banking restrictions) that could derail the forecasted growth trajectory?
How will the forecast influence analyst coverage upgrades/downgrades and target price revisions for the listed cannabis companies?
What macro‑economic factors (inflation, consumer spending, interest rates) could influence the projected CAGR and overall market sentiment?